Randwick, NEW%20SOUTH%20WALES1 Active Studies

Angelman Syndrome Clinical Trials in Randwick, NEW%20SOUTH%20WALES

Find 1 actively recruiting angelman syndrome clinical trials in Randwick, NEW%20SOUTH%20WALES. Connect with local research sites and explore new treatment options.

1
Active Trials
1
Sponsors
70
Enrolling

Recruiting Angelman Syndrome Studies in Randwick

About Angelman Syndrome Clinical Trials in Randwick

Angelman syndrome is a rare genetic disorder primarily affecting the nervous system, characterized by severe developmental delays, speech impairment, seizures, and a happy demeanor. It is caused by loss of function of the UBE3A gene. Treatment focuses on managing symptoms and maximizing developmental potential.

There are currently 1 angelman syndrome clinical trials recruiting participants in Randwick, NEW%20SOUTH%20WALES. These studies are seeking a combined 70 participants. Research is being sponsored by Ionis Pharmaceuticals, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.

Angelman Syndrome Clinical Trials in Randwick — FAQ

Are there angelman syndrome clinical trials in Randwick?

Yes, there are 1 angelman syndrome clinical trials currently recruiting in Randwick, NEW%20SOUTH%20WALES. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Randwick?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Randwick research site will contact you about next steps.

Are clinical trials in Randwick free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Randwick studies also compensate for your time and travel.

What angelman syndrome treatments are being tested?

The 1 active trials in Randwick are testing new therapies including novel drugs, biologics, and treatment approaches for angelman syndrome.

Data updated March 2, 2026 from ClinicalTrials.gov